Biogen Inc.
Biogen Inc., a leading U.S. neurologic biotech, develops and sells therapies for MS, spinal muscular atrophy, and neurodegenerative diseases, with a robust pipeline in Alzheimer’s and Parkinson’s, bolstered by strategic partnerships and global commercial reach.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 7,605
- HQ: Cambridge
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.